Physician profile
Della K Fuller
NPI 1669506713
$3,467.84
in general payments reported to CMS, 2019-2025
38 companies · $1,014 in 2025
The $1,014 reported for 2025 was more than what 97% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $470 · 2022: $828 · 2023: $671 · 2024: $485 · 2025: $1,014.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,169.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $650.11 | 2021-2025 | |
| Gilead Sciences, INC. | $285.85 | 2022-2025 | Yeztugo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $203.30 | 2022-2025 | Xifaxan |
| Astrazeneca Pharmaceuticals Lp | $169.66 | 2023 | Lokelma, Tezspire |
| Novo Nordisk INC | $159.45 | 2022-2025 | Ozempic |
| Scynexis, INC. | $147.54 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $145.31 | 2021-2023 | |
| Hologic Sales and Service, LLC | $143.60 | 2021-2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Aptima |
| Mayne Pharma Commercial LLC | $137.85 | 2021-2024 | |
| Ani Pharmaceuticals, INC. | $112.58 | 2025 | Purified Cortrophin Gel |
| Eisai INC. | $109.22 | 2024 | |
| Radius Health, INC. | $105.26 | 2024-2025 | Tymlos |
| Axonics, INC. | $94.56 | 2024 | Axonics |
| Amgen INC. | $85.42 | 2023 | Repatha |
| Evofem Biosciences, INC. | $77.74 | 2021-2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Della Fuller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.